Бартизар - analogs
Components: Bortezomib |
|||||||||
Pharmgroups: Other antitumor agents || Antitumor drugs other |
|||||||||
| Prices in pharmacies: 136.3€ Instructions Бартизар | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Feloran 25 ✘ (incl) Enalapril-UBF ✘ (incl) Фиточай «Стройная жизнь» ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | neutral Boramilan | 91.7€ |
| ≈100% | neutral Velcade | 140-149.4€ |
| ≈100% | neutral Bortezol | 150€ |
| ≈100% | neutral BoramilanFS | 35-453.9€ |
| ≈100% | neutral Bortezomib | — |
| ≈100% | neutral Verozomib | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 65% — Lenalidomide-nativ neutral [Lenalidomide]
- 57% — Lenalidomide-TL neutral [Lenalidomide]
- 54% — Lenalidomide-KRKA neutral [Lenalidomide]
- 54% — Леналидомид-Тева neutral [Lenalidomide]
- 54% 1328€ Revlimid neutral [Lenalidomide]
- 54% — Леналидомид-промомед neutral [Lenalidomide]
- 54% — Ландотекс neutral [Lenalidomide]
- 54% — Рупсулимид neutral [Lenalidomide]
- 54% — Леналидомид-АМЕДАРТ neutral [Lenalidomide]
- 54% — Мулмилида neutral [Lenalidomide]
- 54% — Ленанжио neutral [Lenalidomide]
- 54% — Леналидомид (форма-Н1) neutral [Lenalidomide]
- 54% — Метибластан neutral [Lenalidomide]
- 54% 937.9€ Миеланикс neutral [Lenalidomide]
- 49% — Карфилзомиб-промомед neutral [Carfilzomib]
- 49% — Карфилзомиб-Гленмарк neutral [Carfilzomib]
- 49% — Карфилза neutral [Carfilzomib]
- 49% — Карфилзомиб авексима neutral [Carfilzomib]
- 49% — Карфилзомиб Фармасинтез neutral [Carfilzomib]
- 49% — Карфилзомиб Дж neutral [Carfilzomib]
- 46% 790€ Kyprolis neutral [Carfilzomib]
- 45% 3947.9€ Калквенс neutral [Akalabrutinib]
- 45% — Калквенс Т neutral [Akalabrutinib]
- 45% 6132.2€ Mozobil neutral [Plerixafor]
- 45% — Акалабрутиниб-Промомед neutral [Akalabrutinib]
- 42% — L-asparaginase for injections Negative 🔍 [Asparaginase]
- 42% 52.2-54€ Vero-Asparaginase Negative 🔍 [Asparaginase]
- 42% 124-174.5€ Asparaginase medac Negative 🔍 [Asparaginase]
- 41% — Asparaginase Negative 🔍 [Asparaginase]
- 40% — L-Asparaginase Negative 🔍 [Asparaginase]
- 40% 2964.5€ Пикрэй neutral [Alpelisib]
- 40% — Олапариб-АМЕДАРТ neutral [Olaparib]
- 38% 15.2-27.8€ Цервикон -ДИМ neutral [Diindolylmethane]
- 38% — Висмодегиб-промомед neutral [Vismodegib]
- 38% — Висмодегиб neutral [Vismodegib]
- 38% — Factor tumor necrosis-thymosine alpha-1 recombinant neutral [Tumor necrosis factor-thymosine alpha-1 recombinant]
- 38% — Metvix neutral [Methylaminolevulinate]
- 37% — Lenalidomide Canon neutral [Lenalidomide]
- 37% — Леноалромид neutral [Lenalidomide]
- 37% — Miltex neutral [Miltefosine]
- 36% 108-879€ Atriance Dangerous 🔍 [Nelarabine]
- 35% — Фаридак neutral [Panobinostat]
- 34% 296€ Halaven neutral [Eribulin]
- 34% — Эрибулин-промомед neutral [Eribulin]
- 34% — Эрибол neutral [Eribulin]
- 34% — Эрибулин Фармасинтез neutral [Eribulin]
- 34% — Эриксаленсе neutral [Eribulin]
- 34% — Eribulin neutral [Eribulin]
- 34% 1440€ Venclexta neutral [Venetoclax]
- 33% 927.6€ Oncaspar Negative 🔍 [Pegaspargase and more 1Asparaginase]
Learn more about the selection of analogues
▶
- The drug has «Бартизар» 14 full analogs, the cheapest - BoramilanFS (35-453.9€); 51 analog by action, the most similar - Revlimid (1328€).
- Medical online service has selected the best substitutes for Бартизар based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Бартизар to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.